However, further research is needed to determine whether administration of a low dose of MLN-4760 can be used in the treatment of COVID-19 with the risk of inducing oxidative stress followed by activation of NRF2-mediated antioxidant mechanisms in the BS. Here, NFE2L2 is linked to COVID-19.